微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 65.3% | -5.11% | -3.14% | 35/131 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 67.42% | -1.75% | 0.84% | 35/131 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 66.86% | -2.52% | -2% | 40/131 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 68.22% | 0.9% | -0.87% | 37/131 | 53.5% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 68.82% | 0.93% | 0.29% | 33/131 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 68.62% | 3.54% | 0.05% | 30/131 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 68.58% | 1.61% | 1.44% | 33/131 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 67.61% | -0.36% | -0.84% | 35/131 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 68.19% | -0.06% | 2.89% | 34/131 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 66.27% | -2.87% | -1.81% | 38/131 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 67.5% | -2.3% | -0.53% | 36/131 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 67.86% | -2.3% | -0.54% | 36/131 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 68.23% | -2.01% | 0% | 34/131 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 68.23% | 0.7% | -1.23% | 41/131 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 69.08% | 2% | -0.54% | 34/131 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 69.45% | 5.43% | -0.25% | 41/131 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 69.63% | 2% | 2.77% | 36/131 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 67.75% | 2.03% | 2.84% | 46/131 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-06-30 | 65.88% | 2% | -0.79% | 42/131 | 59.94% | 正海生物 | 92.69% | 行业排名> |
| 2019-12-31 | 66.4% | 4.48% | 4.48% | 46/131 | 56.37% | 正海生物 | 92.61% | 行业排名> |
| 2018-12-31 | 63.56% | 2% | 2% | 48/131 | 55.53% | 正海生物 | 94.38% | 行业排名> |